HS
HighVista Strategies’s Enliven Therapeutics ELVN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.84M | Buy |
141,516
+29,057
| +26% | +$583K | 1.04% | 21 |
|
|
2025
Q1 | $2.21M | Hold |
112,459
| – | – | 0.85% | 28 |
|
|
2024
Q4 | $2.53M | Hold |
112,459
| – | – | 0.94% | 26 |
|
|
2024
Q3 | $2.87M | Sell |
112,459
-7,330
| -6% | -$187K | 0.99% | 32 |
|
|
2024
Q2 | $2.8M | Sell |
119,789
-7,065
| -6% | -$165K | 1.02% | 26 |
|
|
2024
Q1 | $2.23M | Sell |
126,854
-10,387
| -8% | -$183K | 0.8% | 43 |
|
|
2023
Q4 | $1.9M | Buy |
137,241
+12,654
| +10% | +$175K | 0.69% | 48 |
|
|
2023
Q3 | $1.7M | Buy |
124,587
+3,514
| +3% | +$48K | 0.79% | 39 |
|
|
2023
Q2 | $2.47M | Buy |
+121,073
| New | +$2.47M | 1.13% | 30 |
|